ArticleMolecular psychiatry2026
Prevalent and characteristic alterations in blood-brain transcriptomic-functional imaging coupling in schizophrenia.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Schizophrenia (SCZ) is increasingly recognized as a multi-system disorder characterized by peripheral immunometabolic dysregulation. To investigate system-level blood-brain integration, we analyzed peripheral blood transcriptomics, resting-state fMRI (fALFF), and cognitive data from two cohorts (Discovery: 43 SCZ, 60 HCs; Validation: 41 SCZ, 29 HCs). Seven robust peripheral blood gene co-expression modules associated with SCZ were identified, enriched for immune and metabolic pathways. These modules showed reproducible disease associations in independent blood cohorts. Widespread alterations in functional coupling between these gene modules and intrinsic brain activity (fALFF) were observed in SCZ, characterized by a network-specific reconfiguration with an inverse pattern of correlation changes between limbic and frontoparietal/default mode networks. This dysregulated coupling pattern was highly reproducible across cohorts. We further identified putative core disease-associated module-network pairs: a downregulated metabolic module coupled with frontoparietal/default mode regions, and an upregulated ribosomal module coupled with limbic regions. Integration of these multimodal features yielded a proof-of-concept improvement in SCZ diagnostic classification (AUCs: 0.71-0.77 in an independent temporal but local validation cohort). Correlation and mediation analyses suggested that brain functional activity in these coupled regions may mediate the relationship between peripheral gene expression and cognitive impairment. Collectively, these findings reveal distinct, reproducible dysregulation of peripheral-central functional coupling in SCZ, offering a multi-scale framework for understanding its pathophysiology and highlighting the potential of trans-scale features as candidate biomarkers for diagnosis and mechanistic insight.
Identifiers
42736350What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.